DJIA 17,745.98 -5.41 -0.03%
NASDAQ 5,128.79 17.05 0.33%
S&P 500 2,108.63 0.06 0.00%
market minute promo

Eli Lilly & Co. (NYSE: LLY)



company name or ticker
Company Photos
(Click to zoom)

Eli Lilly's Valuation Getting Stretched?

Another Hot BioPharma IPO: vTv Therapeutics

Why Pharmaceutical Eli Lilly & Co. Warrants Attention from Investors Right Now - Stocks in the News

Merck Tops on Q2 Earnings & Revenues, Revises Outlook - Analyst Blog

Lilly continues test of HDL cholesterol drug, on panel's advice

Lilly Issues Update on Evacetrapib Phase 3 Trial: Last Patient Visit in ACCELERATE Expecting Jul. '1

Lilly Issues Update on Evacetrapib Phase 3 Trial: Last Patient Visit in ACCELERATE Expecting Jul. '16

3 Alzheimer's Drugs Investors Should Be Watching

Motley Fool analysts dive into the next generation of Alzheimer's disease medicines and also tackle risks facing Castlight Health investors.

Eli Lilly, Biogen Present Data at Alzheimer's Association - Analyst Blog

Eli Lilly, Biogen Present Data at Alzheimer's Association - Analyst Blog

Eli Lilly's (LLY) CEO John Lechleiter on Q2 2015 Results - Earnings Call Transcript

AmerisourceBergen Beats on 3Q15 Earnings, Ups View - Analyst Blog

See More Articles...